Market Cap 546.90B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.42
Forward PE 19.86
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 6,863,500
Avg Vol 7,984,782
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 45%
Beta 0.27
Analysts Strong Sell
Price Target $259.92

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
NRG8
NRG8 May. 3 at 12:25 PM
0 · Reply
ElliottwaveForecast
ElliottwaveForecast May. 3 at 12:07 PM
📊 Johnson & Johnson $JNJ – Buyers Zone JNJ is approaching the 227.8–215.8 area, highlighted by Elliott Wave analysis as a key buying zone. The structure suggests upside potential as long as price holds above this support region. Read the full analysis of $JNJ buyign area here 👉 https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #ElliottWave #Trading #Stocks
0 · Reply
CedarPark
CedarPark May. 2 at 9:00 PM
$TGTX ok $JNJ make us a good offer now ;)
0 · Reply
TheUnmaker
TheUnmaker May. 2 at 7:23 AM
$TNXP There is a reason we are an uplisted company. Don't be late to the party. Big things to come! $PFE $LLY $PG $JNJ https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-uplisting-from-nasdaq-capital-market-ok3to5zr8mfo.html
1 · Reply
TheUnmaker
TheUnmaker May. 2 at 7:19 AM
$TNXP This is the news we need to get our Lymes Diaease vaccine off the ground. This administration is causing a big shift in all industries as long as its meeting their standard. Don't be a skeptic, the Kennedys want this approved. Once we get further down the pipeline with FDA approval, than U believe the campaign to promote this will begin. Lymes Diaease effects alot of people and is a growing issue in the Northeast and Northern states of America. Big things coming. Continue to hold the lines bulls! $PFE $LLY $JNJ $PG https://www.hhs.gov/press-room/secretary-kennedy-convenes-lyme-disease-patients-providers-announce-new-diagnostic-efforts.htm
4 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:32 PM
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:14 PM
$TNXP "Wall Street analysts forecast TNXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNXP is 55.42 USD with a low forecast of 34.34 USD and a high forecast of 68.25 USD." https://www.alphaspread.com/security/nasdaq/tnxp/analyst-estimates $PFE $LLY $PG $JNJ
1 · Reply
SlightlyHippy
SlightlyHippy May. 1 at 9:31 PM
$JNJ & $ABBV pick up the dips!!
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 5:36 PM
$TNXP $LLY $PG $JNJ https://www.gurufocus.com/news/8827655/tonix-pharmaceuticals-tnxp-announces-phase-2-study-plans-for-lyme-disease-vaccine?mobile=true
1 · Reply
DragonAlgo
DragonAlgo May. 1 at 5:04 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-15 | Strike: $230.00 | Type: CALL Option Plan (premium): Entry: $3.30 Stop: $2.38 TP1: $4.29 TP2: $5.61 TP3: $7.92 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
Latest News on JNJ
Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 4 days ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 5 days ago

J&J sees AI halving the time to generate drug development leads


Johnson & Johnson Transcript: AGM 2026

Apr 23, 2026, 10:00 AM EDT - 9 days ago

Johnson & Johnson Transcript: AGM 2026


Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:51 AM EDT - 18 days ago

Johnson & Johnson CFO on the company's robotic surgical system


Johnson & Johnson Earnings Call Transcript: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 19 days ago

Johnson & Johnson Earnings Call Transcript: Q1 2026


J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:55 AM EDT - 19 days ago

J&J raises guidance for 2026 on strong start to the year


Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Apr 14, 2026, 6:20 AM EDT - 19 days ago

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook


J&J's First-Quarter Sales Grow on Cancer-Drug Strength

Apr 14, 2026, 6:20 AM EDT - 19 days ago

J&J's First-Quarter Sales Grow on Cancer-Drug Strength


The Big 3: ORCL, JNJ, SBUX

Mar 19, 2026, 1:00 PM EDT - 6 weeks ago

The Big 3: ORCL, JNJ, SBUX

ORCL SBUX


US FDA approves J&J's oral psoriasis pill

Mar 18, 2026, 8:31 AM EDT - 6 weeks ago

US FDA approves J&J's oral psoriasis pill


US FDA approves JNJ's blood cancer drug

Mar 5, 2026, 2:21 PM EST - 2 months ago

US FDA approves JNJ's blood cancer drug


Johnson & Johnson launches website for direct-to-consumer sales

Mar 4, 2026, 6:07 PM EST - 2 months ago

Johnson & Johnson launches website for direct-to-consumer sales


NRG8
NRG8 May. 3 at 12:25 PM
0 · Reply
ElliottwaveForecast
ElliottwaveForecast May. 3 at 12:07 PM
📊 Johnson & Johnson $JNJ – Buyers Zone JNJ is approaching the 227.8–215.8 area, highlighted by Elliott Wave analysis as a key buying zone. The structure suggests upside potential as long as price holds above this support region. Read the full analysis of $JNJ buyign area here 👉 https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #ElliottWave #Trading #Stocks
0 · Reply
CedarPark
CedarPark May. 2 at 9:00 PM
$TGTX ok $JNJ make us a good offer now ;)
0 · Reply
TheUnmaker
TheUnmaker May. 2 at 7:23 AM
$TNXP There is a reason we are an uplisted company. Don't be late to the party. Big things to come! $PFE $LLY $PG $JNJ https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-uplisting-from-nasdaq-capital-market-ok3to5zr8mfo.html
1 · Reply
TheUnmaker
TheUnmaker May. 2 at 7:19 AM
$TNXP This is the news we need to get our Lymes Diaease vaccine off the ground. This administration is causing a big shift in all industries as long as its meeting their standard. Don't be a skeptic, the Kennedys want this approved. Once we get further down the pipeline with FDA approval, than U believe the campaign to promote this will begin. Lymes Diaease effects alot of people and is a growing issue in the Northeast and Northern states of America. Big things coming. Continue to hold the lines bulls! $PFE $LLY $JNJ $PG https://www.hhs.gov/press-room/secretary-kennedy-convenes-lyme-disease-patients-providers-announce-new-diagnostic-efforts.htm
4 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:32 PM
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:14 PM
$TNXP "Wall Street analysts forecast TNXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNXP is 55.42 USD with a low forecast of 34.34 USD and a high forecast of 68.25 USD." https://www.alphaspread.com/security/nasdaq/tnxp/analyst-estimates $PFE $LLY $PG $JNJ
1 · Reply
SlightlyHippy
SlightlyHippy May. 1 at 9:31 PM
$JNJ & $ABBV pick up the dips!!
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 5:36 PM
$TNXP $LLY $PG $JNJ https://www.gurufocus.com/news/8827655/tonix-pharmaceuticals-tnxp-announces-phase-2-study-plans-for-lyme-disease-vaccine?mobile=true
1 · Reply
DragonAlgo
DragonAlgo May. 1 at 5:04 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-15 | Strike: $230.00 | Type: CALL Option Plan (premium): Entry: $3.30 Stop: $2.38 TP1: $4.29 TP2: $5.61 TP3: $7.92 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 2:45 PM
$TNXP the come back is real! $PFE $LLY $JNJ $PG Keep her strong bulls!
0 · Reply
ElliottwaveForecast
ElliottwaveForecast May. 1 at 1:54 PM
$JNJ already hit the daily #Bluebox area & expect buyers to take control soon for next rally It favors 7 swings pullback into 227.8 - 215.8 area and expect to find support to extend January-2025 bull run above 256 or higher. It already reach the area. https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #Elliottwave #JNJ
0 · Reply
hafstein
hafstein May. 1 at 12:49 PM
$AZN $ESPR $JNJ $MRK I hope you’re right. I’m not happy at all with this shit deal. and been holding for 2 years now.
0 · Reply
Petey3163
Petey3163 May. 1 at 12:48 PM
$AZN $ESPR $JNJ $MRK how do you know it’s been published
0 · Reply
Canyonfundstrader2007
Canyonfundstrader2007 May. 1 at 12:47 PM
$ESPR THIS IS NOT A DONE DEAL. Esperion will receive other bids now. $MRK $JNJ $AZN PFE NVS
1 · Reply
stu
stu May. 1 at 12:10 PM
$TGTX OT - $JNJ "The investigational CD20 mono CAR-T cell therapy and CD19-CD20 bi-CAR-T programs will be discontinued." Still a crowded field I think. https://www.jnj.com/media-center/press-releases/johnson-johnson-statement-on-investigational-programs-in-large-b-cell-lymphoma
0 · Reply
JJBurch
JJBurch May. 1 at 11:30 AM
$OSRH remember. The naked shorts MUST be covered today Today A short squeeze is imminent ‼️ 🍊 🧃 💰 $BYND $TSLA $JNJ
2 · Reply
NRG8
NRG8 May. 1 at 10:43 AM
0 · Reply
DragonAlgo
DragonAlgo Apr. 30 at 9:51 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-08 | Strike: $230.00 | Type: CALL Option Plan (premium): Entry: $3.27 Stop: $2.36 TP1: $4.26 TP2: $5.57 TP3: $7.86 🔗 https://dragonalgo.com
0 · Reply
TheUnmaker
TheUnmaker Apr. 30 at 7:26 PM
0 · Reply
TheUnmaker
TheUnmaker Apr. 30 at 7:21 PM
$TNXP There is a reason we are listed on the Nasdaq Global Select Market. $LLY $PFE $JNJ https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-publication-of-steady-state-i7rrq92xb55l.html
0 · Reply
TheUnmaker
TheUnmaker Apr. 30 at 7:18 PM
$TNXP When is $59 gap fill? $PFE $LLY $JNJ https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-presentation-of-phase-1-data-and-zsipiev9xtwa.html
0 · Reply